These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32712748)

  • 1. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
    Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
    Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
    Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
    Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.
    Forghanifard MM; Taleb S; Abbaszadegan MR
    Pathol Oncol Res; 2015 Apr; 21(2):463-7. PubMed ID: 25361534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
    Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
    Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness.
    Golyan FF; Abbaszadegan MR; Forghanifard MM
    J Cell Biochem; 2019 Sep; 120(9):14838-14846. PubMed ID: 31016793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Gene Expr Patterns; 2020 Sep; 37():119127. PubMed ID: 32711119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
    Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM
    Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWIST1 Plays Role in Expression of Stemness State Markers in ESCC.
    Izadpanah MH; Forghanifard MM
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.
    Fardi Golyan F; Forghanifard MM
    Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE-30.
    Mahmoudian RA; Bahadori B; Rad A; Abbaszadegan MR; Forghanifard MM
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00746. PubMed ID: 31090196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 upregulates the MAGEA4 oncogene.
    Forghanifard MM; Rad A; Farshchian M; Khaleghizadeh M; Gholamin M; Moghbeli M; Abbaszadegan MR
    Mol Carcinog; 2017 Mar; 56(3):877-885. PubMed ID: 27533647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
    Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
    Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma.
    Khales SA; Mozaffari-Jovin S; Geerts D; Abbaszadegan MR
    BMC Cancer; 2022 Dec; 22(1):1272. PubMed ID: 36474162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between MEIS1 and markers of different cell signaling pathways in esophageal squamous cell carcinoma.
    Mahmoudian RA; Forghanifard MM
    Mol Biol Rep; 2020 May; 47(5):3439-3448. PubMed ID: 32372171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.